85 related articles for article (PubMed ID: 11056357)
1. Inhibition of nitric oxide (NO) synthesis antagonises the oestrogen-induced increase in coronary blood.
Lang U; Baker RS; Braems GA; Clark KE
Eur J Cancer; 2000 Sep; 36 Suppl 4():111. PubMed ID: 11056357
[No Abstract] [Full Text] [Related]
2. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats.
Pávó I; László F; Morschl E; Nemcsik J; Berkó A; Cox DA; László FA
Eur J Pharmacol; 2000 Dec; 410(1):101-4. PubMed ID: 11134661
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhibition of nitric oxide synthesis in patients with coronary artery disease and stable angina.
Tousoulis D; Davies GJ; Tentolouris C; Crake T; Lefroy DC; Toutouzas P
Eur Heart J; 1997 Apr; 18(4):608-13. PubMed ID: 9129890
[TBL] [Abstract][Full Text] [Related]
5. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
[TBL] [Abstract][Full Text] [Related]
6. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G
J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide activity in the atherosclerotic human coronary circulation.
Quyyumi AA; Dakak N; Mulcahy D; Andrews NP; Husain S; Panza JA; Cannon RO
J Am Coll Cardiol; 1997 Feb; 29(2):308-17. PubMed ID: 9014982
[TBL] [Abstract][Full Text] [Related]
8. Coronary and systemic hemodynamic effects of sustained inhibition of nitric oxide synthesis in conscious dogs. Evidence for cross talk between nitric oxide and cyclooxygenase in coronary vessels.
Puybasset L; Béa ML; Ghaleh B; Giudicelli JF; Berdeaux A
Circ Res; 1996 Aug; 79(2):343-57. PubMed ID: 8756014
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-derived nitric oxide enhances the effect of intraaortic balloon pumping on diastolic coronary flow.
Toyota E; Goto M; Nakamoto H; Ebata J; Tachibana H; Hiramatsu O; Ogasawara Y; Kajiya F
Ann Thorac Surg; 1999 May; 67(5):1254-61. PubMed ID: 10355392
[TBL] [Abstract][Full Text] [Related]
10. Effects of nitric oxide synthesis inhibition on the goat coronary circulation under basal conditions and after vasodilator stimulation.
García JL; Fernández N; García-Villalón AL; Monge L; Gómez B; Diéguez G
Br J Pharmacol; 1992 Jul; 106(3):563-7. PubMed ID: 1504740
[TBL] [Abstract][Full Text] [Related]
11. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
[TBL] [Abstract][Full Text] [Related]
12. Effects of oestrogen upon nitric oxide synthase NADPH-diaphorase activity in the hypothalamo-neurohypophysial system of the rat.
Wang H; Morris JF
Neuroscience; 1999 Jan; 88(1):151-8. PubMed ID: 10051196
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of proximal and distal coronary arteries to a nitric oxide donor following reperfusion injury or inhibition of nitric oxide synthesis.
Coughlan MG; Kenny D; Kampine JP; Bosnjak ZJ; Warltier DC
Cardiovasc Res; 1993 Aug; 27(8):1444-8. PubMed ID: 8221797
[TBL] [Abstract][Full Text] [Related]
14. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction.
Drexler H; Hablawetz E; Lu W; Riede U; Christes A
Circulation; 1992 Jul; 86(1):255-62. PubMed ID: 1617777
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis.
Kato M; Shiode N; Yamagata T; Matsuura H; Kajiyama G
Heart; 1997 Nov; 78(5):493-8. PubMed ID: 9415011
[TBL] [Abstract][Full Text] [Related]
16. Effects of verapamil on the renal actions induced by nitric oxide and prostaglandin synthesis inhibition.
Llinás MT; González JD; Salazar FJ
Am J Hypertens; 1996 Oct; 9(10 Pt 1):973-81. PubMed ID: 8896649
[TBL] [Abstract][Full Text] [Related]
17. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
[TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide and adenosine in control of coronary blood flow in exercising dogs.
Tune JD; Richmond KN; Gorman MW; Feigl EO
Circulation; 2000 Jun; 101(25):2942-8. PubMed ID: 10869267
[TBL] [Abstract][Full Text] [Related]
20. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
